Itaru Naitoh

33PUBLICATIONS
50CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityImmunogenetics (incl. genetic immunology)Rheumatology and arthritisHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Aug 13, 2026
Determinants of Survival Benefit From Endobiliary Radiofrequency Ablation for Extrahepatic Cholangiocarcinoma According to Tumor Stage, Systemic Therapy, and Session Number.

|Jul 22, 2026
Impact of Steroid Pulse Therapy on Early Treatment Response and Relapse in Type 1 Autoimmune Pancreatitis.

|Feb 25, 2026
Clinicopathological features of localized-type IgG4-related cholecystitis: a nationwide multicenter study in Japan.

Itaru Naitoh, Takahiro Nakazawa, Kenji Notohara

|Jan 07, 2026
Multicenter Validation Study of the Clinical Diagnostic Criteria for IgG4-Related Sclerosing Cholangitis 2020 in Japan.

Itaru Naitoh, Takahiro Nakazawa, Kensuke Kubota

|Nov 26, 2025
Endoscopic Stenting for Unresectable Malignant Hilar Biliary Obstruction: Where Do We Stand Today? A Narrative Review.

Tadahisa Inoue, Itaru Naitoh, Michihiro Yoshida

|Sep 17, 2025
Suprapapillary Stent-By-Stent Deployment With Slim-Fully Covered Versus Uncovered Metal Stents for Malignant Hilar Biliary Obstruction: A Multicenter Comparative Study (With Video).

Tadahisa Inoue, Michihiro Yoshida, Naoaki Yamada

Pageof 6

Frequent Collaborators

14 joint publications

Michihiro Yoshida

10 joint publications

Yasuki Hori

8 joint publications

Akihisa Kato

6 joint publications

Hiromi Kataoka